← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Danaher DHR $158B	1,086	+39	+4%	$53.1B
2	2 Thermo Fisher Scientific TMO $249B	1,056	+31	+3%	$51.4B
3	3 Novartis NVS $279B	879	+3	+0.3%	$19.4B
4	4 Agilent Technologies A $49.1B	577	+19	+3%	$12.4B
5	5 Regeneron Pharmaceuticals REGN $80.1B	542	-8	-1%	$25.3B
6	6 Illumina ILMN $41B	526	-26	-5%	$19.8B
7	7 Revvity RVTY $17B	348	+18	+5%	$5.24B
8	8 Charles River Laboratories CRL $14.4B	286	+22	+8%	$3.8B
9	9 Ionis Pharmaceuticals IONS $7.1B	283	-32	-10%	$2.55B
10	10 Myriad Genetics MYGN $397M	253	+19	+8%	$2.5B
11	11 Alnylam Pharmaceuticals ALNY $30B	249	-6	-2%	$4.11B
12	12 Bruker BRKR $8.47B	236	+8	+4%	$2.61B
13	13 DELISTED CATALENT, INC. CTLT	186	+12	+7%	$2.93B
14	ISEE 14 DELISTED IVERIC bio, Inc. Common Stock ISEE	182	+20	+12%	$1.71B
15	15 DELISTED bluebird bio BLUE	177	-10	-5%	$1.9B
16	16 Precigen PGEN $2.64B	169	-22	-12%	$2.45B
17	17 Ultragenyx Pharmaceutical RARE $1.47B	162	0	0%	$1.81B
18	18 Azenta AZTA $1.63B	152	+6	+4%	$717M
19	19 Sarepta Therapeutics SRPT $1.78B	148	+16	+12%	$661M
20	20 Pacific Biosciences PACB $619M	141	+11	+8%	$431M
21	21 DELISTED SANGAMO THERAPEUTICS INC SGMO	136	-7	-5%	$268M
22	22 PTC Therapeutics PTCT $4.98B	118	-1	-0.8%	$202M
23	23 Standard BioTools LAB $248M	97	-3	-3%	$246M
24	AGTC 24 DELISTED Applied Genetic Technologies Corporation AGTC	94	+4	+4%	$153M
25	25 Arrowhead Research ARWR $8.25B	88	+8	+10%	$110M